Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors - New York business news -BoardProspects

Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors

New York business news Nov 18 2019 BoardMoves

Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced the appointment of Morgan Sheng, Ph.D., to its Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Torrence Boone Joins Macy’s Board of Directors also published in New York business news
- Zentalis Pharmaceuticals Appoints David Johnson to Board of Directors also published in New York business news
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- The Future Of Clean Beauty Is Female: Maureen Chiquet, Former Global CEO Of Chanel, Joins Credo Board Of Directors also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned